283 related articles for article (PubMed ID: 11445736)
1. Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.
Faust SN; Heyderman RS; Levin M
Crit Care Med; 2001 Jul; 29(7 Suppl):S62-7; discussion S67-8. PubMed ID: 11445736
[TBL] [Abstract][Full Text] [Related]
2. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.
Dhainaut JF; Yan SB; Cariou A; Mira JP
Crit Care Med; 2002 May; 30(5 Suppl):S318-24. PubMed ID: 12004254
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, sepsis, and coagulation.
Esmon CT; Fukudome K; Mather T; Bode W; Regan LM; Stearns-Kurosawa DJ; Kurosawa S
Haematologica; 1999 Mar; 84(3):254-9. PubMed ID: 10189392
[TBL] [Abstract][Full Text] [Related]
4. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.
Esmon CT
Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734
[TBL] [Abstract][Full Text] [Related]
5. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
Levi M; de Jonge E; van der Poll T
Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740
[TBL] [Abstract][Full Text] [Related]
6. Activated protein C versus protein C in severe sepsis.
Yan SB; Dhainaut JF
Crit Care Med; 2001 Jul; 29(7 Suppl):S69-74. PubMed ID: 11445737
[TBL] [Abstract][Full Text] [Related]
7. Endogenous protein C activation in patients with severe sepsis.
Liaw PC
Crit Care Med; 2004 May; 32(5 Suppl):S214-8. PubMed ID: 15118520
[TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.
Ito T; Thachil J; Asakura H; Levy JH; Iba T
Crit Care; 2019 Aug; 23(1):280. PubMed ID: 31416465
[TBL] [Abstract][Full Text] [Related]
9. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
Maruyama I
Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
[No Abstract] [Full Text] [Related]
10. Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan.
Iba T; Gando S; Thachil J
J Thromb Haemost; 2014 Jul; 12(7):1010-9. PubMed ID: 24801203
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation.
Van de Wouwer M; Collen D; Conway EM
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1374-83. PubMed ID: 15178554
[TBL] [Abstract][Full Text] [Related]
12. Effects of anticoagulant strategies on activation of inflammation and coagulation.
Feistritzer C; Wiedermann CJ
Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
[TBL] [Abstract][Full Text] [Related]
13. Microvascular coagulopathy and disseminated intravascular coagulation.
ten Cate H; Schoenmakers SH; Franco R; Timmerman JJ; Groot AP; Spek CA; Reitsma PH
Crit Care Med; 2001 Jul; 29(7 Suppl):S95-7; discussion S97-8. PubMed ID: 11445741
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
Maruyama I
Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
[TBL] [Abstract][Full Text] [Related]
15. Thrombomodulin in sepsis.
Levi M; Van Der Poll T
Minerva Anestesiol; 2013 Mar; 79(3):294-8. PubMed ID: 23241735
[TBL] [Abstract][Full Text] [Related]
16. Coagulation inhibitor substitution during sepsis.
Fourrier F; Jourdain M; Tournois A; Caron C; Goudemand J; Chopin C
Intensive Care Med; 1995 Nov; 21 Suppl 2():S264-8. PubMed ID: 8636534
[TBL] [Abstract][Full Text] [Related]
17. [Protein C and coagulation in sepsis].
D'Angelo A; Della Valle P; Giudici D; Viganò D'Angelo S
Minerva Anestesiol; 2004 May; 70(5):339-50. PubMed ID: 15181414
[TBL] [Abstract][Full Text] [Related]
18. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
19. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].
Kinasewitz GT; Yan SB; Basson B; Comp P; Russell JA; Cariou A; Um SL; Utterback B; Laterre PF; Dhainaut JF;
Crit Care; 2004 Apr; 8(2):R82-90. PubMed ID: 15025782
[TBL] [Abstract][Full Text] [Related]
20. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
Iba T; Nagaoka I; Boulat M
Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
